Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Kenvue
KVUE
|
+$344M |
| 2 |
JPMorgan Chase
JPM
|
+$161M |
| 3 |
Extra Space Storage
EXR
|
+$134M |
| 4 |
GE HealthCare
GEHC
|
+$113M |
| 5 |
Ferguson
FERG
|
+$97.1M |
Top Sells
| 1 |
PDCE
PDC Energy, Inc.
PDCE
|
+$313M |
| 2 |
Super Micro Computer
SMCI
|
+$305M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
+$176M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$160M |
| 5 |
Walmart
WMT
|
+$112M |
Sector Composition
| 1 | Technology | 17.36% |
| 2 | Financials | 16.12% |
| 3 | Industrials | 12.99% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Healthcare | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Fresenius Medical Care
FMS
$14.6B
| $323K | ﹤0.01% |
14,997
-9,147
| -38% | -$197K |
|
3127
Soho House & Co
SHCO
$1.73B
| $319K | ﹤0.01% |
+46,045
| New | +$319K |
|
|
EFXT
3128
Enerflex
EFXT
$1.26B
| $319K | ﹤0.01% |
55,626
| – | – |
|
3129
USCB Financial Holdings
USCB
$349M
| $319K | ﹤0.01% |
30,335
+10,388
| +52% | +$109K |
|
3130
Acumen Pharmaceuticals
ABOS
$81.8M
| $314K | ﹤0.01% |
75,602
+6,623
| +10% | +$27.5K |
|
|
PFIN
3131
DELISTED
P&F Industries
PFIN
| $311K | ﹤0.01% |
46,791
-1,410
| -3% | -$9.38K |
|
3132
Verastem
VSTM
$608M
| $310K | ﹤0.01% |
38,155
-482
| -1% | -$3.92K |
|
3133
Smith-Midland
SMID
$215M
| $309K | ﹤0.01% |
16,286
+233
| +1% | +$4.42K |
|
3134
FinWise Bancorp
FINW
$259M
| $309K | ﹤0.01% |
35,716
+8,272
| +30% | +$71.5K |
|
3135
HireQuest
HQI
$133M
| $308K | ﹤0.01% |
19,977
| – | – |
|
|
NEXN
3136
Nexxen International
NEXN
$606M
| $307K | ﹤0.01% |
86,918
-3,287
| -4% | -$11.6K |
|
3137
Pyxis Oncology
PYXS
$116M
| $306K | ﹤0.01% |
153,771
+136,281
| +779% | +$271K |
|
3138
Tucows
TCX
$194M
| $304K | ﹤0.01% |
14,888
-1,899
| -11% | -$38.8K |
|
|
DM
3139
DELISTED
Desktop Metal, Inc.
DM
| $303K | ﹤0.01% |
20,830
-7,306
| -26% | -$106K |
|
|
FORTY
3140
Formula Systems
FORTY
$2.22B
| $300K | ﹤0.01% |
4,126
-177
| -4% | -$12.9K |
|
3141
XBiotech
XBIT
$85.4M
| $298K | ﹤0.01% |
72,475
-1,839
| -2% | -$7.57K |
|
3142
ImmuCell
ICCC
$55.7M
| $297K | ﹤0.01% |
57,594
-6,670
| -10% | -$34.4K |
|
3143
Solid Power
SLDP
$645M
| $294K | ﹤0.01% |
145,692
+76,500
| +111% | +$155K |
|
3144
Semrush
SEMR
$1.1B
| $294K | ﹤0.01% |
34,603
+18,601
| +116% | +$158K |
|
3145
Codexis
CDXS
$219M
| $292K | ﹤0.01% |
154,985
-121,598
| -44% | -$229K |
|
3146
Babcock & Wilcox
BW
$266M
| $291K | ﹤0.01% |
69,177
-20,464
| -23% | -$86.2K |
|
|
OGI
3147
Organigram Holdings
OGI
$221M
| $289K | ﹤0.01% |
219,127
-3,504
| -2% | -$4.63K |
|
3148
McEwen Inc.
MUX
$742M
| $288K | ﹤0.01% |
44,309
+28,355
| +178% | +$184K |
|
3149
Reservoir Media
RSVR
$511M
| $284K | ﹤0.01% |
46,623
+20
| +0% | +$122 |
|
3150
UWM Holdings
UWMC
$1.49B
| $284K | ﹤0.01% |
+58,501
| New | +$284K |
|